Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
Pharma-Bio Serv, Inc. functions as a specialized consulting firm, providing services focused on regulatory compliance and the transfer of technology. The company offers its compliance expertise to a diverse range of clients, including those in the pharmaceutical, chemical, biotechnology, medical device, cosmetic, and food industries, as well as related product companies. Its operational reach extends across Puerto Rico, the United States, Europe, and Brazil. The firm's technical advisory offerings encompass vital areas such as regulatory adherence, system validation, technology migration, engineering solutions, comprehensive project management, and ongoing process support. Established in 1993, Pharma-Bio Serv maintains its corporate headquarters in Dorado, Puerto Rico.
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2026
Pharma-Bio Serv reported revenue of approximately $2.7 million for the quarter ended April 30, 2026, an increase of $0.3 million compared to the prior year.
Net income for the quarter was approximately $0.2 million, up $0.1 million year-over-year, while six-month revenue reached $5.0 million with net income of $0.3 million.
Management attributed the improved financial performance to a strategic focus on high-return markets and disciplined cost management.